← SynDRA
BESIFLOXACIN
SynDRA canonical compound SYN0023608 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Mechanism of action | bacterial DNA gyrase inhibitor |
|---|
| Indication | conjunctivitis |
|---|
| Disease area | ophthalmology |
|---|
All known targets
- Bact gyrA
- Bact gyrB
- Stap-coc parC
- gyrA
- gyrB
- parC
- parE
Mechanisms of action (all sources)
- DNA gyrase inhibitor
- Bact gyrA; Bact gyrB MODULATOR
- Stap-coc parC MODULATOR
- parC INHIBITOR
- parE INHIBITOR
- gyrA INHIBITOR
- gyrB INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Antineoplastic Agents
- Enzyme Inhibitors
- Topoisomerase II Inhibitors
- Topoisomerase Inhibitors
- Quinolone Antimicrobial
ATC classes
Cross-references
Synonyms
- BESIVANCE
- Besivance
- besifloxacin hydrochloride
- besivance
- SS734
- BOL-303224-A
- besifloxacin HCl
- Besifloxacine
- Besifloxacino
- ISV-403
- Besivance (TN)
- BESIFLOXACINE
- BFE2NBZ7NX
- besifloxacino
- besifloxacinum
- RefChem:56416
- DTXCID0084197
- S01AE08
- Besifloxacin [INN]
- UNII-BFE2NBZ7NX
- BESIFLOXACIN [MI]
- BESIFLOXACIN [VANDF]
- BESIFLOXACIN [MART.]
- BESIFLOXACIN [WHO-DD]
- SCHEMBL725805
- orb1704847
- GTPL12877
- CHEBI:135622
- EBC-26926
- EX-A12240
- s5941
- AKOS005145882
- AC-8867
- NCGC00386381-02
- NCGC00386381-04
- HY-14762
- CS-0003546
- NS00069194
Look up BESIFLOXACIN in the interactive SynDRA portal →